Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein ZAR1-like (ZAR1L) is a member of the ZAR1 family of proteins and is predominantly expressed in oocytes and early embryos. It plays a crucial role as an mRNA-binding protein required for maternal mRNA storage, translation, and degradation during oocyte maturation. ZAR1L is believed to regulate the formation of phase-separated membraneless compartments that sequester maternal mRNAs and modulate their translation by binding to 3'-UTR regions, thereby preventing premature translation during early embryonic cell cycles. Mutations in ZAR1L have been associated with certain developmental disorders, but it is not documented as a pharmacological or therapeutic target[2][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein ZAR1-like (ZAR1L).